Syngene International stock gained 1.62 percent on October 6, 2026

Published on 10/07/2026 at 00:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Syngene International stock gained 1.62 percent to INR 363.20 on October 6, 2026. Q1 FY27 revenue fell 16 percent and the company reported a INR 90 million loss.

Syngene, INE398R01022, Illustration mit AI erstellt.

Syngene International stock (ISIN INE398R01022) was last at INR 363.20 on the NSE on October 6, 2026, up 1.62 percent from the prior close. The latest quarter put that market move against a difficult operating backdrop, with Q1 FY27 revenue down 16 percent year over year to INR 7.36 billion.

Quarterly loss resets the baseline

According to Sahi Markets, Syngene reported the June 30, 2026 quarter with a consolidated net loss of INR 90 million, compared with a net profit of INR 870 million in Q1 FY26. Operating EBITDA was INR 910 million, and the margin contracted to 12 percent from 24 percent in the year-earlier quarter.

The earnings profile therefore changed on two fronts at once. Revenue fell by INR 1.40 billion from the comparable quarter, while the bottom line swung by INR 960 million from profit to loss, making client demand and cost control the central operating variables for the next reporting cycle.

Guidance points to a recovery test

Zerodha reports that management lowered FY27 revenue guidance from flat growth to a single-digit decline in rupee terms, while retaining an EBITDA margin goal in the mid-20s. That guidance is materially different from the Q1 margin of 12 percent and leaves the second half of FY27 responsible for the planned improvement.

The company is also moving through a leadership transition. Siddharth Mittal became managing director and chief executive officer on July 1, 2026, according to Sahi Markets, replacing Peter Bains. Syngene describes itself as an integrated research, development and manufacturing organization serving pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical clients on its investor page.

Trading window raises results interest

A company filing reported by Daily Briefer said the trading window closed on October 1, 2026, ahead of unaudited results for the quarter and half year ending September 30, 2026. The next result set will show whether the Q1 revenue decline and 12 percent EBITDA margin were temporary or part of a longer reset.

For investors, the key comparison is between the FY27 margin ambition in the mid-20s and the 12 percent delivered in Q1. The stock also remains close to its October 6 session low of INR 353.30, while the 52-week range extends to INR 678.95, leaving the reported results and guidance as the main measures of operational recovery.

Syngene stock trades at INR 363.20

Syngene International stock was last at INR 363.20 on the NSE on October 6, 2026, with a market capitalization of INR 146.2 billion and volume of 319,107 shares. The 52-week range was INR 353.30 to INR 678.95, placing the price INR 10.00 above the session low.